Search - tctmd.com

Displaying 601 - 620 of 1160

Sort: Relevancy | Date

News Conference News ACC 2016

HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not

Michael O'Riordan

April 02, 2016

News Daily News

Same-Day Discharge After PCI Is Safe, With Benefits for Patients and Hospitals: Review

Todd Neale

April 01, 2016

News Daily News

美国指南更新，将接受 DES 的稳定患者的 DAPT 持续时间从 12 个月下调为 6 个月

Yael L. Maxwell

March 30, 2016

News Daily News

Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES

Yael L. Maxwell

March 30, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2016

Shelley Wood

March 30, 2016

News Daily News

Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF

Yael L. Maxwell

March 30, 2016

News Opinion Editor's Corner

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Shelley Wood

March 28, 2016

News Daily News

Mammogram-Derived Clues to Cardiovascular Disease Often Unreported and Ignored

L.A. McKeown

March 25, 2016

News Daily News

Un Nuevo Análisis del COGENT Avala el Uso de PPI en Pacientes con Dosis Bajas de Aspirina

Caitlin E. Cox

March 23, 2016

News Daily News

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

Caitlin E. Cox

March 23, 2016

News Daily News

COGENT 新分析支持对低剂量阿司匹林患者使用 PPI

Caitlin E. Cox

March 23, 2016

News Daily News

Does New Dual-Modality Imaging Come Closer to Uncovering Vulnerable Plaques?

Todd Neale

March 14, 2016

News Daily News

在出血风险高的患者中新一代 DES 加简化 DAPT 优于 BMS

L.A. McKeown

March 08, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Daily News

Los SLF de Nueva Generación Con Tratamiento Antiplaquetario Doble Abreviado Superan a los SMD en Pacientes de Alto Riesgo Hemorrágico

L.A. McKeown

March 08, 2016

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

News Industry News

Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack

February 18, 2016

News Daily News

Complex Lesions, Thrombus During PCI May Spell Trouble After DES Implantation

Todd Neale

February 07, 2016

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

February 04, 2016

News Daily News

FDA 的前职员表示，各抗血栓试验的缺失数据使得药物作用蒙上疑云

Shelley Wood

January 18, 2016

Advertisement

HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not

Same-Day Discharge After PCI Is Safe, With Benefits for Patients and Hospitals: Review

美国指南更新，将接受 DES 的稳定患者的 DAPT 持续时间从 12 个月下调为 6 个月

Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES

TCTMD’s Top 10 Most Popular Stories for March 2016

Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Mammogram-Derived Clues to Cardiovascular Disease Often Unreported and Ignored

Un Nuevo Análisis del COGENT Avala el Uso de PPI en Pacientes con Dosis Bajas de Aspirina

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

COGENT 新分析支持对低剂量阿司匹林患者使用 PPI

Does New Dual-Modality Imaging Come Closer to Uncovering Vulnerable Plaques?

在出血风险高的患者中新一代 DES 加简化 DAPT 优于 BMS

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

Los SLF de Nueva Generación Con Tratamiento Antiplaquetario Doble Abreviado Superan a los SMD en Pacientes de Alto Riesgo Hemorrágico

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack

Complex Lesions, Thrombus During PCI May Spell Trouble After DES Implantation

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

FDA 的前职员表示，各抗血栓试验的缺失数据使得药物作用蒙上疑云

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content